Evidence map›Paper›PMID 30186137›Full record

ArticleCase reports in oncology

Searching for the Culprit: Metastases from a Cancer of Unknown Primary.

Rita Dorantes-Heredia, Daniel Motola-Kuba, Jose Manuel Ruiz-Morales, Wallace Rafael A Muñoz-Castañeda, Carolina Vega-Ochoa, Roberto De la Peña

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rita Dorantes-HerediaAnatomic Pathology Research Unit, Médica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
Daniel Motola-KubaOncology Research Unit, Médica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
Jose Manuel Ruiz-MoralesOncology Research Unit, Médica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
Wallace Rafael A Muñoz-CastañedaInternal Medicine Research Unit, Médica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
Carolina Vega-OchoaFacultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Roberto De la PeñaOncology Research Unit, Médica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
Hospital Médica Sur · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of metastases from a cancer of unknown primary whose primary site could not be identified during the appropriate pretreatment evaluation. The patient was a 58-year-old woman with a history of passive smoking and with no history of cancer in the family. Her current condition started with asthenia, adynamia, and pallor, followed by palpitations. An abdominopelvic computed tomography (CT) scan was performed, showing multiple osteolytic lesions distributed in all bone structures and axillary adenopathy on the left side. As part of the approach and given the high suspicion of multiple myeloma, tests were performed. The results were negative for multiple myeloma. A PET-CT scan was performed and showed left axillary adenopathy. The breasts and other organs were not affected. Left axillary lymph node resection revealed breast primary metastatic pleomorphic lobular carcinoma. Due to the metastatic disease (caused by the primary breast cancer), it was decided to start chemotherapy.

Indexed as

Breast cancerCancer of unknown primaryMetastasis

Identifiers

PMID30186137
PMCPMC6120367
OpenAlexW2887742699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.